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 Venlafaxine (VFA) was treated by 5
Advanced Oxidation Processes
(AOPs).
 The degradation kinetics were
systematically assessed in water,
wastewater and urine.
 UV light and HO-induced attacks
degraded VFA even in the chemically
complex matrices.
 The degradation pathway was
elucidated, indicating biodegradable
intermediates.
 Increase of biodegradability was
observed by applying AOPs prior to
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In this work, the use of Advanced Oxidation Processes (AOPs) against the degradation of an emerging con-
taminant has been subjected under systematic investigation. The optimization of treatment of the anti-
depressant drug Venlafaxine (VFA) was performed, using UV light, the combined UV/H2O2 process, solar
light, Fenton and finally the solar photo-Fenton process in laboratory scale. The degradation kinetics, the
time necessary to remove 90% of the contaminant and the optimal reactants concentration were pro-
posed. The treatment in pure water, (synthetic) wastewater and urine was assessed, in an effort to iden-
tify the opportunities and pitfalls the application of process would encounter in a field application.
Treatment by the UV-based methods was found sufficiently efficient and the application of the solar
photo-Fenton process showed feasibility in a potential field application with appropriate context. Real
urban wastewater effluents after biological and physicochemical treatment were tested, as well as
human urine, as a proposal for on-site collection and treatment was also treated. Biological treatment
before applying the tested AOPs improved their efficiency, and the strategy of diluting urine prior to
treatment greatly enhanced the efficacy of the process. Finally, the identification of the degradation path-
way and the biodegradability tests of AOPs treated VFA solutions exhibit promising results concerning
the strategy of treatment for similar pollutants of emerging concern.
 2016 Elsevier B.V. All rights reserved.
S. Giannakis et al. / Chemical Engineering Journal 308 (2017) 492–504 4931. Introduction required time to capture their prey (minnows), and the analysisDuring the last years, research has focused on the new chal-
lenges and problems that have emerged in Environmental Engi-
neering and more specifically, wastewater (WW) treatment.
Water scarcity and reuse [1], emerging pollutants [2] and the rise
of antibiotic resistance [3] are only a few that are closely related
to the absence of potent measures to limit or mitigate their effect.
With that being said, wastewater treatment plants (WWTPs) hold
their fair share of blame for inefficiently stopping some of the new
threats.
One of the most crucial problems the WWTPs face, and is con-
nected with the improvement of life standards globally, is the per-
ception of illness and the ways drugs are administered nowadays.
Apart from the physical illnesses, injuries etc. which require antibi-
otics, sanitizers and similar products, the taboos of psychological
conditions have crumbled and as their recognition as ‘‘equally
important” illnesses is established, and treatment is now consid-
ered as nothing out of the ordinary. The intense ways of living have
been proven to increase the stress levels of people, leading to anx-
iety and chronic symptoms, as serious as sleep deprivation or
depression [4]. The administration of proper medication has led
to the second problem WWTPs have to face: emerging
contaminants.
Venlafaxine (VFA, brand name: Effexor XR, Lanvexin or Tre-
vilor), is an anti-depressant, which belongs in the general family
of selective serotonin and norepinephrine reuptake inhibitors
(SSNRIs) [5,6]. Practically, it treats depression, anxiety and panic
disorders by increasing the concentrations these natural
substances in the body and brain of the patient [7,8]. Chemically,
it belongs to the class of benzene and substituted derivatives and
is a tertiary amino compound that is N,N-dimethylethanamine
substituted at position 1 by a 1-hydroxycyclohexyl and
4-methoxyphenyl group (Table 1). Its excretion from the body
follows the renal route, ends up in WWTPs, and therefore it is
found in natural waters as VFA, plus its metabolites are escaping
in almost 50% rate the wastewater treatment process [9–12].
Measured concentrations range from 18 to 122 ng L1 for VFA
[13], or 102 and 690 ng L1 [11,14] which could affect the natural
biota.
Since this compound lacks functional groups that hydrolyze
under environmental conditions (pH 5–9), hydrolysis is not
expected to be an important environmental process, and therefore
the risk of bioaccumulation is possible. With an estimated bio-
concentration factor (BCF) of 60, the potential for bio-
concentration in aquatic organisms is classified as moderate [15].
Furthermore, the exposure experiments of Bisesi et al. [16] have
indicated that Venlafaxine exposures of bass increased theTable 1
Venlafaxine characteristics and physicochemical properties [15].
Compound Chemical structure Molecular
weight (g/mol)
W
so
(m
Venlafaxine C17H27NO2
277.402
26
a: [23], b [24], c [21], d [25], e[26].of brain tissues revealed that VFA caused decrease in brain sero-
tonin concentrations, thus explaining the behavior changes. Fong
and Molnar [17] investigated the biological effects of antidepres-
sants comprising VFA on the mollusks and crustaceans, i.e. foot
detachment, a potentially sub-lethal effect that could result in
transport to unfavorable habitats for the target organisms; VFA
exposure caused this effect even by exposure to concentrations sig-
nificantly lower than the ones found in WWTP effluents [18]. The
question is due to the food chain and cycle of water, how this is
going to demonstrate on human beings in long term.
As there risks similar to VFA in WW are increasing, WWTPs
need to adapt to modern era threats more effectively. Under this
spirit, the new Swiss regulations for wastewater treatment include
a list of 12 priority contaminants for elimination fromWWTPs, and
VFA has become one of the recent additions to that list [19]. The
said regulation involves the upgrade of WWTPs to employ acti-
vated carbon, ozone or another Advanced Oxidation Process
(AOP) and ensure 80% removal of the chosen micropollutants. As
it appears, AOPs can play an important role acting as a barrier for
contaminants of emerging concern before reaching natural waters
[20–22].
Recently, works have been initiated on the systematic degrada-
tion of VFA by UV/H2O2 and TiO2 photocatalysis [23,24] dealing
with the elucidation of the degradation pathway by these methods
and also focusing on the toxicological safety of the degradation by-
products. To contribute to this end, in our work we employ 5
Advanced Oxidation Processes (UV, UV/H2O2, solar light, Fenton,
solar photo-Fenton) to degrade VFA in the matrices mostly
expected to be encountered. After a systematic investigation of
the opportunities and pitfalls of treatment in water, urban wastew-
ater effluents and human urine containing VFA are employed and
the degradation efficiency is assessed. Finally, we investigate the
degradation pathway of VFA inflicted by the various AOPs and
explore the use of AOPs as a pre-treatment step to increase the
biodegradability of this contaminant with the Zahn-Wellens
tests.2. Materials and methods
2.1. Chemicals and reagents
The chemicals for the experiments were used as received. Ven-
lafaxine HCl (see Table 1) was acquired from TCI (Germany), the
HPLC solvents (acetonitrile, acetic acid and ammonium acetate)
and the Fenton reagents (hydrogen peroxide 30% and iron sulfate
heptahydrate) were acquired from Sigma-Aldrich (Switzerland).ater
lubility
g/L)
log
kow
pKa Henry’s coefficient (H)
(atm m3/mol)
HO reaction rate
constant (M1 s1)a,b,c,d,e
7 3.20 10.01 2.0 x 1011 (8.15 ± 0.4)  109
(8.46 ± 0.5)  109
(8.8 ± 1.5)  1091010
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The preparation of the synthetic matrices involved dissolution
of 100 mg/L VFA in either Mili-Q (MQ) water (18.2 MX cm1),
synthetic wastewater (SWW) or synthetic urine (SUR), and all
UV-related MQ experiments were conducted at near-neutral pH.
The composition of the synthetic matrices is presented in Table 2.
The pH of the simulated wastewater and urine is 7 and 6.5, respec-
tively. The real WW effluents range from 6.5 to 7.5, so the pH was
near-neutral unless otherwise indicated. Real wastewater
samples were collected from the local wastewater treatment plant
of Vidy, Lausanne (Switzerland), after an activated sludge process,
a moving bed bio-reactor or a coagulation-flocculation unit. The
corresponding (initial) concentrations before treatment were
determined by HPLC/MS and were around 300 ng L1. For the real
urine experiments, 10 lg/L VFA was added prior to
experimentation.
2.3. Light sources and corresponding reactors-experimental apparatus
For the UV and UV/H2O2 experiments, two double-wall, water-
jacketed glass batch reactors were used in parallel. The sample was
placed within and the lamps, covered by a quartz sleeve were then
submerged in it. The monochromatic, Hg discharge UV-C lamps
(5  103 mW/cm2 measured by iodide/iodate actinometry [25])
were 11-W Philips TUV mini (11W/G11 T5 UV) with
I11W = 26 lW/cm2. For protection of the UV equipment and stan-
dardized conditions, water at 22 C was recirculated with a Neslab
RTE-111 thermostat. A similar set-up, but with a 35-W lamp was
used for the real WW and urine experiments.
For solar and photo-Fenton experiments, a Hanau Suntest CPS
solar simulator was used, employing a 1500-W Xenon lamp,
equipped with UVC and IR cut-off filters. The intensity was set at
900 W/m2 and temperature was kept below 38 C at all times by
air-cooling. The Pyrex-glass reactors were kept in constant
agitation (350 rpm) by magnetic bars. The (dark) Fenton tests were
performed in identical reactors and conditions without providing
light to the system.
2.4. Analytical methods
2.4.1. Venlafaxine determination routine by HPLC
The determination of Venlafaxine concentration was performed
through HPLC. An HP 1100 Agilent series HPLC was used. Briefly,Table 2
Composition of the synthetic matrices used in this study.
Name Chemical
formula
SWW
composition [mg/L]
Synthetic wastewater
Peptone – 160
Meat extract – 110
Urea CH4N2O 30
Dipotassium phosphate HK2PO4 28
Sodium chloride NaCl 7
Calcium chloride dihydrate CaCl22H2O 4
Magnesium sulfate heptahydrate MgSO47H2O 2
Name Chemical
formula
SUR
composition [g/L]
Synthetic urine
Urea CH4N2O 25
Sodium chloride NaCl 2.925
Sodium sulfate Na2SO4 2.25
Potassium chloride KCl 1.6
Potassium phosphate monobasic KH2PO4 1.4
Calcium chloride dihydrate CaCl22H2O 1.103
Creatinine C4H7N3O 1.1
Ammonium chloride NH4Cl 1the mobile phase consisted of 0.14 M ammonium acetate buffer,
(1.079 g/L acidified with glacial acetic acid (pH = 4). This was then
mixed with 10% methanol/acetonitrile solution and sonicated for
15 min. Finally, filtration from 0.45 lL membrane was done. The
HPLC conditions consisted of 40 C temperature, 20 lL injection
volume, RP-C18 column (4.6 mm  250 mm) and detection of the
peaks at 254.4 nm.2.4.2. Venlafaxine quantification by UPLC/MS in real WW and RU
An online SPE-UPLC/MS-MS (Acquity Xevo-TQ, Waters) was
used. Samples were acidified to pH = 2.0 (32% chlorhydric acid),
spiked with a standard mixture of surrogate, containing the MPs
in deutered form and filtered with glass fiber filter (Simplepure
PP + GF, 0.22 lm, 25 mm, BGB). Standard solutions have followed
the same preparation. Five milliliters of each sample were loaded
on an SPE column (Oasis HLB 25 lm, 2.1  20 mm, Waters) with
ultrapure water, acidified at 1% of formic acid, as eluent. The online
transfer of VFA to the analytical column (Acquity HSS T3, 1.8 lm,
2.1  100 mm, Waters) was made with a gradient of ultrapure
water and acetonitrile acidified at 0.1% of formic acid. Multiple
reaction monitoring mode with two transitions was used to detect
MPs and quantification was performed with internal standard
calibration.2.4.3. Intermediates identification by TOF-MS analysis
HR-MS analyses were conducted on a Xevo G2-S QTOF mass
spectrometer coupled to the Acquity UPLC Class Binary Solvent
Manager and BTN Sample Manager (Waters, Corporation, Milford,
MA). Mass spectrometer detection was operated in positive ioniza-
tion using the ZSprayTM dual-orthogonal multimode ESI/APCI/ESCi
source. Samples were diluted in H2O and directly infused into the
mass spectrometer at a flow rate of 100 lL/min. The TOF mass
spectra were acquired in the sensitive mode over the range of
m/z 50–1200 at an acquisition rate of 1 s/spectra. A mass accuracy
better than 5 ppm was achieved using a leucine-encephalin solu-
tion as lock-mass (200 pg/lL in ACN/H2O (50:50)) infused contin-
uously using the LockSpray source (5 s reference Scan frequency).
Source settings were as follows: cone, 25 V; capillary, 3 kV, source
temperature, 120 C; desolvation temperature, 500 C, cone gas,
100 L/h, desolvation gas, 500 L/h. Data were processed using
MassLynxTM 4.1 software.2.4.4. Global chemical analyses (TOC, COD, H2O2 and UV/Vis
absorbance)
The COD of the solution was monitored with HR/LR dichromate
vials (HACH Lange, Switzerland) and TOC was followed by a
Shimadzu TOC-VCSN analyzer, with an ASI-V automatic sampling
moduleH2O2 was determined spectrophotometrically, after the
addition of 10 lL of titanium oxysulfate in 1 mL of sample and
measurement at 410 nm (DIN 38402H15 method). Finally, the
absorbance spectra was recorded at each sampling point (Shi-
madzu 1800 UV spectrophotometer) and the pH was followed by
a Mettler-Toledo Seven Easy pH meter.3. Results and discussion
3.1. UV-based AOPs degradation of Venlafaxine
3.1.1. Monochromatic UV-C photolysis
Fig. 1 presents the photolysis of Venlafaxine (VFA), under the
exposure to monochromatic UV-C (peak at 253.7 nm) irradiation,
at neutral pH. The photolysis rates, quantum yields and the proven,
but limited efficiency to degrade VFA by UV light in a collimated
beam apparatus have been recently documented [23,26]. The kphot
Fig. 1. Summary of the UV-C photolysis experiments. (a) UV-induced degradation of Venlafaxine followed by HPLC, COD removal and TOC reduction during UV photolysis. (b)
Evolution of the COD/TOC ratio.
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work.
In our work, a merry-go-round reactor with submerged lamp
was employed and the corresponding kinetics are depicted in
Fig. 1. In principle, the degradation follows a linear trend in (natu-
ral) logarithmic scale which allows the determination of first-order
reaction kinetics, being 0.0104 cm2/mJ, calculated as follows:
½I ¼ ½I0ekt ð1Þ
or as:
ln½It ¼ ln½I0  kt ð2Þ
By re-arranging the equation 1, we get:
ln
It
I0
 
¼ kt ð3Þ
Due to the reactor design and configuration, the actual irradi-
ance received by the system and determined by iodide/iodate acti-
nometry [25] is 0.005 mW/cm2, which is much higher than the
collimated beam apparatus. Since the degradation follows first-
order kinetics, the time necessary to degrade 90% of the initial con-
centration (t90%) has been determined and will be used for compar-
ison among the various processes. From (3), by substitution we
get:
ln
0:1I0
I0
 
¼ kt ð4Þ
or:
t90% ¼  ln0:1k ð5Þ
The required time for 90% was 163 min and until the t90% was
reached, the UV-C system removed 7% and 4% of COD and TOC.
Even by extending the treatment for 4 h, UV-C alone is not suffi-
cient to degrade more than 20% of COD or remove more than
15% of TOC. As it appears, the complex VFA structure is affected
by UV in the double bonds present but light alone cannot effi-
ciently mineralize the carbon content of the solution attributed
to the degradation by-products and intermediates. Fig. 1b corrobo-
rates with the findings, and the depicted COD/TOC ratio presents
asymptotic, plateau-like tendencies. This reveals the formation
and accumulation of stable by-products, which after an initial fast
oxidation, do not further undergo significant modification or min-eralization. Furthermore, Fig. S1 of the supplementary material
also confirms this tendency, where the absorbance spectra indicate
that although VFA is removed (1st peak) a plateau is reached after
2 h of exposure, where a formation of intermediates is stable and
fails to proceed further.
3.1.2. UV/H2O2 Advanced Oxidation Process
Following the UV photolysis, the same set-up was used to
induce UV/H2O2 advanced oxidation of VFA. As indicated in many
studies, the H2O2 addition must be assessed [27], therefore here
in a H2O2 dosing optimization process 5 different H2O2 addition
levels were tested, and the results are summarized in Fig. 2a and b.
The homolytic disruption of the HO–OH bond results in the
release of hydroxyl radicals (HO) [28]. The addition of H2O2 and
the production of HO has a direct effect on the degradation of Ven-
lafaxine. Hydroxyl radicals can act on molecules via oxidation, –OH
substitution, protonation, as well as water abstraction and decar-
boxylation, as seen in related works [23,24]. These attacks drasti-
cally modify the properties of VFA and proceed to more efficient
degradation than UV alone.
The addition of even 5 mg/L H2O2 improved the VFA degrada-
tion 20% respectively, compared to the sole UV experiments. VFA
has –OCH3 and –OH groups that react fast when faced to hydroxyl
radicals (order of kHO  109 M1 s1 and 108 M1 s1, respectively),
but also a –CN group that has a much slower rate constant
(kHO  107 M1 s1) [15], hence the overall degradation rate will
be determined by these groups and the direct photolysis rate
(kphot) when treated by the UV/H2O2 process.
The stepwise increase in H2O2 concentration reveals the
changes in degradation kinetics and the limitations of the
employed experimental system (Fig. 2a and b). After 50 mg/L the
improvement in reaction kinetics is marginal (data for 100 mg/L
not shown). In addition, in [23,26], the photolysis rate was
considerably lower than the corresponding rate for oxidation due
to the hydroxyl radicals, and was considered negligible. Here, the
oxidation kinetics are estimated as follows:
ki ¼ kphot þ kHOi ð6Þ
where, i: the H2O2 addition (mg/L)
As an example, the kHO/kphot ratio was calculated 5.5 for 10 mg/
L (more details are given in Table 3). Hence, although these mea-
surements reveal the high contribution of the photolysis in the
process, they can be partially attributed to the specific reactor
Fig. 2. UV/H2O2 Advanced Oxidation of Venlafaxine: degradation and process optimization. (a) Degradation of VFA by UV/H2O2 with addition of 5–50 mg/L H2O2. (b)
Evolution of COD/TOC ratio (for 50 mg/L initial H2O2 addition). (c) Consumption of H2O2 (black axis and traces) and changes in the t90% (blue axis and traces) as a function of
initial H2O2 amounts. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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tion is small. Therefore, this design influences the economical
parameters of the degradation process.
Nevertheless, the consumption of H2O2 increases with increas-
ing addition. We further notice that the overall oxidation of the
system proceeds towards mineralization of the existing carbon
content for each case. A 4-h exposure to UV/H2O2 system with
50 mg/L H2O2 (i.e. for as long as there was H2O2 present) the
COD and TOC removal is improved compared to the plain UV sys-
tem, and an additional 20% was removed for both parameters.
However, according to the absorbance spectra recorded, after the
removal of VFA, the remaining intermediates and by-products
are not removed equally fast, and a lower second order kHO must
be in effect (detailed graphs can be found in the Supplementary
Fig. S2).
3.2. Fenton-related AOPs degradation of Venlafaxine
In order to fully attribute the effects of the synthetic photo-
Fenton process against the degradation of VFA, a stepwise con-
struction of the process took place. Hence, solar exposure, Fenton
treatment in the dark and the combined process took place and
the results are presented in the respective groups. To our knowl-
edge, this is the first instance where VFA is systematically treatedTable 3
Measured pseudo-first order degradation kinetics of Venlafaxine per AOP and matrix.
Pseudo first order reaction kinetics k (min1)
UV alone MQ
k11Wphot 0.0141
UV/H2O2 MQ kHO=kphot
k11W5 0.0392 1.78
k11W10 0.0757 4.37
k11W20 0.1412 9.01
k11W50 0.2948 19.91
k11W100 0.3726 25.43
Solar light MQ Synergy12.5|58.3 =
kpF
kFþksol
k900sol 0.0002 89.46
Fenton (pH = 3) MQ
k12:5j58:3F 0.0026
photo-Fenton (pH = 3) MQ
k5j10pF
0.0161
k5j50pF 0.1443
k12:5j30pF
0.1814
k12:5j58:3pF
0.2505
k20j50pF
0.2363by the photo-Fenton process and therefore, the different parts will
be analyzed separately.3.2.1. Solar photolysis of Venlafaxine
The experiments of simulated solar exposure of VFA were per-
formed in order to establish solar photolysis rates and check the
potential photo-transformation of the drug. Santoke et al. [29]
proved that Venlafaxine is undergoing limited photolysis. Here,
after 24 h of irradiation at relatively high solar irradiance
(900W/cm2) a mere 12% of the initial VFA amount has been
removed. As such, a ksol = 0.0002 min1 was measured (Table 3).
As far as the COD and TOC of the solution are concerned, limited
removal was observed. COD was removed at 13% and 4% TOC
was eliminated during the course of 24 h (for more details, see
Supplementary Fig. S2). However, the direct action of solar light
includes (1) the excitation of the organic compound at singlet-
excited state [30], (2) its intersystem crossing to triplet state and
(3) its reaction with oxygen to form singlet oxygen [31]. After-
wards, the micropollutant returns to ground state, but the singlet
oxygen created by the reaction with water participates in (i) the
superoxide radical anion formation from oxygen and consequently
(ii) to the formation of H2O2 from water [31] or (iii) the direct
attack to double bonds present in the molecule. Although of lesser
importance, these results will play the role of reference when the
photo-Fenton process will be described from its parts.3.2.2. Fenton-driven degradation of Venlafaxine in the dark
The degradation of VFA in the dark due to the Fenton reaction
was assessed in a range of parameters, such as the initial pH and
the starting Fenton reagents concentration. Literature suggests
that the reactivity of Venlafaxine with hydroxyl radicals is ranging
among 8  109 to 1010 M1 s1 (see Table 1) and that the Fenton
reaction contribution is important, when the reagents concentra-
tion is increased [32]. Fig. 3 presents 4 of the Fe|H2O2 ratios tested
(indicatively chosen), in the 3 different pH levels of operation, i.e. 3,
5 and 7. The results of the optimization are summarized in Fig. 3a
(analytical data in Supplementary Figs. S3a–S3c), for 24 h of treat-
ment for each batch process.
As expected, Fig. 3 shows that at pH = 3 the results were opti-
mal (see also Table 3), as the Fenton process greatly benefits of
the soluble iron at that pH [33]. Although limited by the regenera-
tion of Fe3+ back to Fe2+, 3 out of the 4 processes were able to
degrade more than 50% of the initial content. These processes con-
tained H2O2 in the highest amount, which played the role of the
reductant of ferric iron, as indicated in the following reactions:
Fe2þ þH2O2 ! Fe3þ þ OH þHO ð7Þ
Fig. 3. Fenton-driven Advanced Oxidation of Venlafaxine: degradation and process optimization. (a) Degradation of VFA by the Fenton process, by addition of various Fe|H2O2
ratios. (b) Evolution of COD/TOC ratio (for the same Fe|H2O2 ratios).
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HO2 ¡H
þ þ O2  ð9Þ
HO þH2O2 ! HO2  þH2O ð10Þ
HO þ Fe2þ ! Fe3þOH ð11Þ
Fe2þ þHO2  þHþ ! Fe3þ þH2O2 ð12Þ
Fe3þ þHO2  ! Fe2þ þ O2Hþ ð13Þ
HO2  þHO2  ! H2O2 þ O2 ð14Þ
The generation of the Reactive Oxygen Species (ROS) by the
Fenton process is dependent on the catalyst regeneration, i.e. the
Fe3+ turnover back to Fe2+. However, the reaction kinetics of Eq.
(7) compared with the others is orders of magnitude higher, and
for this reason, the regeneration of the catalyst, especially by Eq.
(8), is considered a limiting step. In water, Fe3+ forms different
aqua-complexes, according to its pH, with precipitation tendencies
as the pH increases. The iron speciation in water changes according
to the Pourbaix diagram and Salgado et al. [34] have updated the
original contribution, with the most recent knowledge. At acidic
pH, the most abundant form of iron is [Fe2+] which is the strongest
reductive form. The optimal value to perform the Fenton reaction is
near 3; from pH 0–4, the rate increases with the pH [35]. After this
pH, the majority of the iron species are insoluble (Fe2O3, or other
colloidal forms) and therefore, the reactivity drops.
However, moving up to pH = 5 the degradation potential is
diminished and only the 20|50 addition Fe|H2O2 ratio was
sufficient to inflict a 70% degradation after 24 h. At pH = 7 this ratio
was limited to a 35% degradation of VFA. Nevertheless, as a suffi-
cient amount of H2O2 was still measured after 24 h, the process
could continue, albeit in lower rates. At pHP5, solid Fe(OH)2 spe-
cies dominate, since they are more readily oxidized (compared to
Fe2+ and FeOH+) [36]. Nevertheless, until pH 5.8 the contribution
of the homogeneous photo-Fenton is still considerable [37]. Finally
among pH 5 and 7 (up to 8), solid iron species dominate and no
further increase in its concentration appear [36]. However, at this
pH HO2 is formed in higher quantities and indirectly helps the
Fe2+ formation through the Eq. (13) [38]. The soluble iron species
have very different rate constants reported, which practicallymeans that their participation in redox reactions depends on the
distribution of these species (Fe2+, FeOH+, and solid Fe(OH)2) [36].
As pseudo-first order kinetics were established for the degrada-
tion process, the t90% was established for each ratio and pH level. It
can be observed that the theoretical t90% can reach 1000 h in the
near-neutral pH and low Fe|H2O2 ratios, although increasing the
amounts can reduce it to merely a day, which is great improve-
ment. The acidic pH on the other hand ensures proper removal
and never exceeds 100 h of treatment, while 11 h are necessary
with high reactants concentration.
Finally, during the 24-h treatment by the Fenton process the
mineralization rate of the organic matter remains low for high
pH and low concentrations of Fe and H2O2. The biggest removal
noted was at pH = 3 and 20|50 ratio. Nevertheless, the COD/TOC
ratio indicates a fast initial degradation step and a decelerated pro-
cess afterwards. As no process was H2O2-limited for any pH or
ratio, this indicates that the VFA structure contains some easily
removed groups, which readily react with the HO radicals (see
Supplementary Fig. S4 and Table S1, for analytical COD & TOC mea-
surements, and H2O2, respectively). In Fig. 4, axis x shows the
wavelength (nm), y the absorbance (a.u.) and z either the Fe|
H2O2 ratio (left group) or the pH level (right group). The corre-
sponding absorbance spectra indicate the formation of different
intermediates and complexes with iron, depending on the pH
and the Fe|H2O2 ratio. Nevertheless, the VFA removal is confirmed
to be low for most cases, and the participation of the iron is
demonstrated by the absorbance in higher wavelength UV and vis-
ible light; Fe can bind to acidic groups or side-chains and create
stable organo-complexes. Also, the stability of the solution after
6 h, indicates the low levels of reaction with the organics present.
However, these absorbance spectra suggests that these complexes
are photo-active, as they absorb UV and visible light in higher rates
than the original solution with iron (t = 0) and therefore we antic-
ipate their possible involvement in the photo-Fenton process.3.2.3. The photo-Fenton driven degradation of Venlafaxine
The final step in this section considers the combined photo-
Fenton process mode of action. In Fig. 5, we summarize the exper-
iments performed, in a similar manner to the Fenton process. As
pseudo-first order kinetics were established, Fig. 5a shows the evo-
lution of t90% as the Fenton reactants and the pH levels increase
(detailed data on the photo-Fenton action can be found in the Sup-
plementary Fig. S5 and the H2O2 consumption at Table S1). A very
Fig. 4. Absorbance spectra during the 24-h Fenton treatment of Venlafaxine, for various Fe|H2O2 ratios (panels a–d) and pH levels (panels i–iii). Fe|H2O2 ratios: (a) 5|10,
pH = 3. (b) 5|50, pH = 3. (c) 12.5|30, pH = 3. (d) 20|50, pH = 3. pH levels: (i) 20|50, pH = 3. (ii) 20|50, pH = 5. (iii) 20|50, pH = 7.
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even the theoretical one is now measured in minutes rather than
hours. The synergy of the Fenton with light is very high, yielding
t90% as low as 10 min for 20|50 at pH = 3.
As the mode of action of the Fenton process has been previously
explained, here we will assess only the changes and improvements
inflicted by light. The most notable difference among these results
and the Fenton process in the dark, is the change in the time scale,
from hour to minute range. Here, all experiments were completed
within 3 h. Although some processes (5|10 ratio) did not conclude,
the great number of completed experiments within the
experimental time demonstrates the efficiency of the photo-
Fenton process. In presence of light, the iron recycling is
facilitated by the absorption of light by the photosensitive aqua-
hydroxy- and organo-complexes. At pH = 3, the prevalent form is
[Fe(H2O)5(OH)]2+; in general, the photo-reduction can beFig. 5. Treatment of Venlafaxine by the photo-Fenton process (irradiance: 900 W/m2).
evolution by the solar photo-Fenton process at various Fe|H2O2 ratios (pH = 3) and incresummarized with the following two reactions 15 and 16, also lead-
ing to an extra hydroxyl radical production:
Fe3þ þH2Oþ hv ! ½FeðH2OÞðOHÞ2þ þHþ ð15Þ½FeðH2OÞ5ðOHÞ2þ þ hv ! Fe2þ þHþ þHO ð16Þ
At higher pH, the contribution in radicals’ formation is reduced,
along with the photo-active compounds concentration. The pro-
duction of the hydroxyl radical, as described before, induces
hydroxylation of two possible sites simultaneously or indepen-
dently, or even reaction with the nitrogen group [29], resulting
to efficient degradation [39,40].
As the mineralization rate indicates (Fig. 5b), the overall
removal of organic matter in the solution stays limited, within
the duration of the experiment. According to the H2O2 consump-(a) Evolution of the t90% with increasing Fe|H2O2 ratio and pH. (b) COD/TOC ratio
asing pH for a 20|50 ratio.
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than the respective after 24 in its Fenton counterpart, the process
is, or will be, H2O2-limited for some combinations. Hence, the
COD and TOC removal is halting and re-dosing would be necessary
to continue the degradation (detailed COD and TOC measurements
can be found in the Supplementary Fig. S6).
Finally, the combined photo-Fenton process effects are also
demonstrated in the changes in absorbance spectra, in Fig. 6. The
photoactivity of the complexes remains high, which means an
active ligand-to-metal charge transfer could be facilitated:
½Fe3þ  L3þ þ 2H2O !hvðLMCTÞ ½FeðH2OÞ22þ þ Lþ ð17Þ
The sacrificial ligand is offered from either VFA or some degra-
dation intermediate and the regenerated Fe2+ will re-participate in
the Fenton reaction. The changes found can be grouped under
either (i) the higher complex formation (higher absorbance) com-
pared to the Fenton system, (ii) the significantly faster plateau
achievement or (iii) the bigger differences in the neutral and
near-neutral process (differences between pH = 3 and 7).3.3. Venlafaxine degradation experiments in wastewater and urine
3.3.1. Experiments in real secondary wastewater effluents and human
urine
The occurrence of VFA and its metabolites in surface waters [11]
indicates the improper elimination in WWTPs and their extreme
adverse effects underlines the need for their degradation prior to
their discharge, with AOPs able to play the last, polishing step
[41]. Table 4 summarizes literature values and own measurements
of VFA in WWTPs, at various stages, from influents to effluents.
In our work, we assessed the degradation of VFA with the same
AOPs analyzed in the previous parts, found in three different sec-
ondary effluents, namely activated sludge (AS), moving bed bio-
reactors (MBBR), and coagulation-flocculation effluent. For more
information on the nature and the composition of the effluents,
as well as COD and TOC removal, interested readers should referFig. 6. Absorbance spectra during the 3-h photo-Fenton treatment of Venlafaxine, for var
pH = 3. (b) 5|50, pH = 3. (c) 12.5|30, pH = 3. (d) 20|50, pH = 3. pH levels: (i) 20|50, pH = 3to [19,42,43,44] and our supplementary material (Table S2).
Fig. 7 depicts the degradation measurements in the two families
of AOPs per process and per effluent. As expected, the UV-based
AOPs presented the fastest degradation kinetics, as summarized
also in Table 4.
Recent works have demonstrated their efficiency in VFA degra-
dation by the Fenton and Fenton-like processes ([22,40]), confirm-
ing the feasibility of its application in real WW samples.
Venlafaxine degradation is a function of contradicting factors in
real effluents. On the antagonists of the process, we can mention
the (i) suspended solids, blocking UV and solar light transmission,
(ii) the Effluent Organic Matter (EfOM), consisting in still particu-
late organic matter (POM), biodegradable organic matter, refrac-
tory organic matter and other MPs, which all compete for the
oxidants generated by AOPs [19] and screen the light [30], (iii)
the ROS scavengers, such as (bi)carbonates, nitrate and nitrite
[31], and (iv) the microorganisms. On the other hand, the very
presence of some substances has been proven to enhance the
self-purification capabilities of the effluents, such as (a) the pres-
ence of photo-sensitizable organic matter (PhOM), which further
produces ROS, and (b) the nitrates and the carbonates, which con-
tribute in producing nitrate radicals, carbonate radicals and ROS,
all with mild oxidative potential [19]. In the end, what we perceive
as ‘‘degradation” is the net force of all these factors, which leans on
the negative side overall, compared to simulated WW or water.
As far as the initial content is concerned, the similar values in AS
and MBBR have been recently verified [45] and the close values in
CF effluents are a result of the low solubility and the hydrophobic-
ity, as expressed by the logkow; VFA tends to adsorb to the gener-
ated flocs and is ‘‘removed” by settling. More specifically, the
degradation kinetics follow a similar trend to the content of sus-
pended matter and organic content in the effluents, as well as
the alkalinity of the matrix, an indicator of (bi)carbonates content
and therefore a precursor of HO scavenging. As shown in [43–45],
the physicochemical characteristics of the effluents measured, ver-
ify a trend, as the MBBR effluents have the best characteristics for
applying AOPs, followed by AS and then CF.ious Fe|H2O2 ratios (panels a–d) and pH levels (panels i–iii). Fe|H2O2 ratios: (a) 5|10,
. (ii) 20|50, pH = 5. (iii) 20|50, pH = 7.
Fig. 7. Treatment of Venlafaxine by AOPs in urban WW effluents. The experimental conditions are marked in the corresponding graphs. (a) VFA degradation by UV-based
AOPs in AS, MBBR and CF effluents. (b) VFA degradation by the Fenton-related processes in AS, MBBR and CF effluents.
Table 4
Occurrence and fate of Venlafaxine in urban WW effluents.
Venlafaxine occurrence in WWTPs
Treatment stage Quantity (ng/L) Source
Pre-treatment Influent 500–1100 [10]
800 [11]
623 ± 18 Own measurements
235 ± 21 [39]
Primary treatment 374 ± 111 Own measurements
Secondary Treatment Biological treatment (high/low HRT) 900–1000 [10] Degradation of Venlafaxine (this work)
140–150 [40] Measured pseudo-first order kinetics k (min1)
95–188 [39] UV-C UV/H2O2 Solar Fenton photo-Fenton
AS 281 ± 83 Own measurements 0.073 nc 0.0001 0.006 0.033
MBBR 224 + 67 Own measurements 0.08 nc 0.0001 0.007 0.035
CF 299 + 9 Own measurements 0.042 nc 0.0001 0.001 0.032
Effluents 95–188 [39]
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facturer, medical and pharmaco-kinetical data, we have found that
the normal dose of Venlafaxine (as Effexor) for patients is 75 mg/-
day and can reach up to 150 mg/day in severe cases. Out of the
administered amount, 92% is recovered in urine, as the renal excre-
tion pathway is prevailing. However, VFA in urine appears in only
5% (1–10% [10]), unconjugated O-desmethyl Venlafaxine (29%),
conjugated O-desmethyl Venlafaxine (26%), 1% N-desmethyl Ven-
lafaxine, and the rest as the other intermediates. Hence, a normal
person excretes 2 L urine per day, it is normal to expect lg/L con-
centrations in patients. As such, 10 lg/L spiking was performed in
urine collected by healthy individuals. The COD of the solution var-
ied significantly from 2.5 to 8.5 g/L. Therefore, collection and
homogenization over the course of 6 h was performed to mitigate
the differences in chemical and optical properties. The average
urine characteristics can be found in the supplementary material
(Table S2). Besides, 10% diluted urine experiments took place, to
assess the possibility of yielding higher UV transmittance in
exchange of higher treatment volumes. The results of the study
are summarized in Fig. 8.
During the experiments in undiluted urine, the efficacy of UV
alone in degrading VFA was low. As urine contains light absorbing
compounds (organic matter, nitro-, phosphoro- and other groups),
light attenuation was a limiting step in the degradation process
[44]. The step-wise addition of H2O2 (50 and 100 mg/L) was benefi-cial, reaching up to 30% degradation of VFA. Other researchers
have also demonstrated the increase in PhACs’ degradation by the
addition of H2O2 in the bulk [46]. The positive aspects of H2O2 addi-
tion are found also in the COD removal, where up to 15% of COD and
13% of DOCwere removed. In real urine, this amount corresponds to
750 mg/L, from a 5000-average COD. Diluting the urine 10 times
has modified the matrix significantly, allowing up to 80% degrada-
tion of VFA (spiking was done after dilution) and the H2O2 addition
further improved degradation, up to 100%.
Furthermore, the dilution of urine has been studied in another
contaminant (Iohexol) by our group [47], and the optimization
experiments revealed that a near-optimal performance could be
obtained by 10% dilution of the matrix. The effect of dilution
improves the transmittance of urine, thus improving light absorp-
tion by the organic matter in solution, but also improve the homo-
lytic disruption of H2O2, the subsequent increase in HO production
and the decrease in scavenging by the organic matter. On the other
hand, the 10 times increase of the treated volume holds technical
and engineering implications, as well as questions on the water
used for dilution. Here, as a proof of concept we have shown that
the effects are multiple and since the human urine production is
small, even this dilution is not a limiting agent to a potential
application.
Finally, no photo-Fenton experiments were performed as the k
in synthetic urine was too low and the treatment of urine in open
Fig. 8. Treatment of Venlafaxine by UV-based methods in human urine. (a) VFA degradation by UV-based AOPs (0, 50 or 100 mg/L H2O2 and 0/100% or 10–90% urine/water
ratio. (b) COD reduction and DOC (0.45 lm filtration) removal in the same conditions.
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could be suggested as a potential substitute for monochromatic
UV or solar light, as they emit an array of peaks and photo-
Fenton reaction could be sustained.
3.4. Elucidation of the AOP-driven degradation pathway and inherent
biodegradability properties of Venlafaxine
3.4.1. Degradation pathway of Venlafaxine by AOPs through TOF-MS
The identification of degradation products is essential for
providing the risk assessment information of drug residues in
the environment, as well as for the improvement of water treat-Fig. 9. Combined Venlafaxinment technologies. In our study, Venlafaxine degradation
products were identified after each degradation procedure (UV,
UV/H2O2, solar treatment, Fenton and solar photo-Fenton). All
identified products were shown in supplementary Table S4,
including their molecular formula, theoretical and experimental
m/z value, double bond equivalent (DBE) and mass accuracy in
ppm (accepted structures with error less than 5 ppm). Ten degra-
dation products were identified in overall: one for solar treat-
ment, six for UV treatment, five for UV/H2O2 treatment, seven
for Fenton degradation and seven for photo-Fenton treatment.
Based on the identified structures, a simple mechanistic scheme
was proposed (Fig. 9).e degradation pathway.
Fig. 10. Zahn-Wellens inherent biodegradability test of Venlafaxine and treated solutions. (a) ZW test after treatment of 50% of the initial VFA solution. (b) ZW test after
treatment of 100% of the initial VFA solution. Note that results are normalized towards the initial DOC to enable comparison.
502 S. Giannakis et al. / Chemical Engineering Journal 308 (2017) 492–504Transformation of Venlafaxine can occur via four dominant
reactions: (1) sequential hydroxylation of the aromatic ring, (2)
transformation of the methoxy- group, (3) hydroxylation and
shortening of the cyclohexanol ring and (4) attack on the nitrogen
group. Firstly, the degradation pathway of VFA was sequential
hydroxylation: once hydroxylated VFA yielding m/z 294.2072
(P8) was identified in all treatments except solar treatment; fol-
lowed by di-hydroxylated product withm/z 310.202 (P9) identified
in UV, UV/H2O2 and photo-Fenton treatment; and tri-hydroxylated
product with m/z 326.1956 (P10) identified only in the UV treat-
ment (Treatment B). The sequence of the identified hydroxylated
degradation products implies that UV light was the main driving
force in the multiple hydroxylation of the aromatic ring. Here,
the identified products were also reported in the literature
[23,24,29,48]. Santoke et al. identified two products formed by
the attack of HO radical on the aromatic ring and the N-chain,
but they were not identified in this study (marked with red dashed
arrow in the degradation pathway) [29].
A second degradation pathway started with dehydrated Ven-
lafaxine’s product m/z 260.2012 (P6), identified in all degradation
procedures. Combinations of dehydration and hydroxylation reac-
tions present a transformation pathway also dominant for VFA UV/
TiO2 treatments [24]. HO attack on the tertiary C-atom and cyclo-
hexanol structure led to the formation of products with m/z
215.1431, m/z 229.1429 and m/z 292.1914; P4, P5 and P7,
respectively.
Demethylation presents a well-known VFA transformation
route in biological and chemical reactions [29,49,50]. Transfor-
mation of the methoxy group was identified within the products
m/z 121.0654 (P1), m/z 178.1231 (P2) and m/z 194.1182 (P3),
which were at the same time the final degradation products. Ali-
phatic nitrogen products identified by Garcia-Galan et al. [23],
were not identified in this study, however they were also
included in the degradation scheme (marked with blue dashed
arrow in the degradation pathway) to complement the overall
VFA degradation routes. It should be noted that the structures
of identified products for different UV/H2O2 treatments depend
not only on the reaction time, but also on the H2O2
concentration used in the experiments. Finally, the appearance
of apparent biodegradable compounds calls for assessment of
the biodegradability assessment of VFA and the AOP-treated
effluents containing it.3.4.2. Zahn-Wellens (ZW) biodegradability test of AOP-treated
Venlafaxine solutions
As literature suggests low removal of VFA in WWTPs, we
assessed the biodegradability of VFA, by subjecting it first through
an AOP. This strategy has been successfully used in various efflu-
ents [51,52]. Therefore, treatment of VFA solutions until 50% and
100% initial concentration degradation, along with a reference
compound (diethylene glycol) and untreated VFA were subjected
to a 28-day Zahn-Wellens inherent biodegradability tests [53,54].
In parallel, DOC was followed at the corresponding blanks (test
suspension and inoculum blank). In order to avoid self-inhibition
problems, the initial VFA amount was reduced to 10 mg/L. The
results of the study are summarized in Fig. 10.
First of all, the test is considered valid as 70% of the initial DOC
of the reference compound has been degraded (>72%) within
14 days. This indicates the suitability of the activated sludge inocu-
lum. Secondly, VFA alone was removed at 35%, which corresponds
to similar degradation rates of VFA in biological treatment facilities
(see Table 4). As far as the applied AOPs are concerned, 50% pre-
treatment of VFA resulted in 20–25% biodegradability improve-
ment. The most efficient process was the photo-Fenton reaction,
only by marginal difference. According to TOF-MS analysis for
VFA in this work, and Orbitrap-MS for Iohexol [44], using AOPs
where iron is involved always leads to enhanced modifications
on the target contaminant. If VFA was eliminated 100% a further
10–15% was achieved, depending on the process. This indicates
that over the course of 28 days, almost 70% of the initial DOC
was eliminated, reaching the threshold for considering the solution
biodegradable. Of course, further treatment of the parent solutions
would achieve the threshold with greater ease, and correlation
with the initial DOC removal should be made instead. Hence, by
extrapolation, it could be possible to propose a pre-treatment step
in industries or hospitals, where mass flows of similar contami-
nants are released, if the said facilities do not employ their own
WWTPs, as it would seriously ease the burden off the municipal
WWTPs.4. Conclusions
The ubiquitous presence of drugs in surface waters demands
strict control frameworks and efficient removal methods at the
S. Giannakis et al. / Chemical Engineering Journal 308 (2017) 492–504 503level of WWTPs. Under this scope, the degradation of the antide-
pressant Venlafaxine was systematically investigated, through
the application of 5 AOPs. UV-based technologies (UV-C light alone
and UV/H2O2) and Fenton-related techniques (solar photolysis,
Fenton and photo-Fenton oxidation) were assessed as control mea-
sures and their efficiency was estimated.
The investigation on the degradation kinetics has shown that
Venlafaxine demonstrates moderate photolysis under UV, and
the addition of H2O2 with the simultaneous HO generation
enhances the degradation potential of the chosen treatment. On
the other hand, solar photolysis was found limited, but in combina-
tion with the action of the Fenton process (in the dark), the photo-
Fenton process was efficient in degrading the contaminant, with
decreasing, but not diminishing performance tendencies as we
approached the neutral pH.
The tests in wastewater and urine revealed a drop in efficiency,
due to the presence of antagonists in the matrix. Urban wastewater
and human urine tests indicated that the actual conditions
expected in the field demand intensive treatment; in wastewater
the degradation of Venlafaxine is subjected to similar problems
as most ng L1 contaminants present, but the efficient removal is
possible, and the human urine experiments indicate an innovative
treatment proposal, by the use of UV to collect and treat on-site the
emerging contaminants, and addition of H2O2, if high simultaneous
DOC removal is desired, before dispersion in the wastewater
matrices.
The mechanistic interpretation (degradation pathway) based on
our own TOF-MS experiments and recent advances in the field
revealed the opportunity of converting Venlafaxine to its bio-
degradable intermediates. The Zahn-Wellens tests performed
showed that pre-treatment of Venlafaxine solutions increases
biodegradability, and under certain conditions, conversion of the
mixture of intermediates into biodegradable is possible.
In the light of the above findings, we conclude that the non-
selective and highly oxidative character of the Advanced Oxidation
Processes is capable in controlling substances before their dis-
charge in natural aquifers and their upcoming environmental con-
sequences. Environmental protection has a well-established ally in
traditional contaminant categories (priority pollutants, organic
matter) and the application of AOPs can play a role of outmost
importance towards this direction in the near future.
Acknowledgments
Stefanos Giannakis acknowledges the Swiss Agency for Devel-
opment and Cooperation (SDC) and the Swiss National Foundation
for the Research for Development Grant, for the funding through
the project ‘‘Treatment of the hospital wastewaters in Côte d’Ivoire
and in Colombia by advanced oxidation processes” (Project No.
146919).Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.cej.2016.09.084.
References
[1] B. Jimenez, T. Asano, Water reclamation and reuse around the world, in: Water
reuse: an international survey of current practice, issues and needs, 2008, pp.
3–26. Available from: <https://books.google.ch/books?hl=en&lr=&id=
zYcTnBmZeIcC&oi=fnd&pg=PA3&dq=Water+reclamation+and+reuse+around+
the+world,+Water+reuse:+an+international+survey+of+current+practice&ots=
XxdS0bnnZ5&sig=hFOfm_XR07x3UWbkabCrIf3hPlE#v=onepage&q=Water%20
reclamation%20and%20reuse%20around%20the%20world%2C%20Water%20
reuse%3A%20an%20international%20survey%20of%20current%20practice&
f=false>.[2] S.D. Richardson, T.A. Ternes, Water analysis: emerging contaminants and
current issues, Anal. Chem. 77 (2005) 3807–3838.
[3] G.M. Rossolini, F. Arena, P. Pecile, S. Pollini, Update on the antibiotic resistance
crisis, Curr. Opin. Pharmacol. 18 (2014) 56–60.
[4] M. Melchior, A. Caspi, B.J. Milne, A. Danese, R. Poulton, T.E. Moffitt, Work stress
precipitates depression and anxiety in young, working women and men,
Psychol. Med. 37 (2007) 1119–1129.
[5] J.M. Andrews, P.T. Ninan, C.B. Nemeroff, Venlafaxine: a novel antidepressant
that has a dual mechanism of action, Depression 4 (1996) 48–56.
[6] A.T. Harvey, R.L. Rudolph, S.H. Preskorn, Evidence of the dual mechanisms of
action of venlafaxine, Arch. Gen. Psychiatry 57 (2000) 503–509.
[7] USNLM, Venlafaxine, in, U.S. National Library of Medicine, 2016.
[8] E.B. Weller, R.A. Weller, G.P. Davis, Use of venlafaxine in children and
adolescents: a review of current literature, Depress. Anxiety 12 (2000) 85–89.
[9] A. Lajeunesse, S.A. Smyth, K. Barclay, S. Sauvé, C. Gagnon, Distribution of
antidepressant residues in wastewater and biosolids following different
treatment processes by municipal wastewater treatment plants in Canada,
Water Res. 46 (2012) 5600–5612.
[10] C.D. Metcalfe, S. Chu, C. Judt, H. Li, K.D. Oakes, M.R. Servos, D.M. Andrews,
Antidepressants and their metabolites in municipal wastewater, and
downstream exposure in an urban watershed, Environ. Toxicol. Chem. 29
(2010) 79–89.
[11] P.C. Rúa-Gómez, W. Püttmann, Occurrence and removal of lidocaine, tramadol,
venlafaxine, and their metabolites in German wastewater treatment plants,
Environ. Sci. Pollut. Res. 19 (2012) 689–699.
[12] L.B. Stadler, L. Su, C.J. Moline, A.S. Ernstoff, D.S. Aga, N.G. Love, Effect of redox
conditions on pharmaceutical loss during biological wastewater treatment
using sequencing batch reactors, J. Hazard. Mater. 282 (2015) 106–115.
[13] P.C. Rúa-Gómez, W. Püttmann, Degradation of lidocaine, tramadol, venlafaxine
and the metabolites O-desmethyltramadol and O-desmethylvenlafaxine in
surface waters, Chemosphere 90 (2013) 1952–1959.
[14] M.M. Schultz, E.T. Furlong, D.W. Kolpin, S.L. Werner, H.L. Schoenfuss, L.B.
Barber, V.S. Blazer, D.O. Norris, A.M. Vajda, Antidepressant pharmaceuticals in
two US effluent-impacted streams: occurrence and fate in water and sediment,
and selective uptake in fish neural tissue, Environ. Sci. Technol. 44 (2010)
1918–1925.
[15] USNLM, Venlafaxine Hydrochloride, in, 2016.
[16] J.H. Bisesi, W. Bridges, S.J. Klaine, Effects of the antidepressant venlafaxine on
fish brain serotonin and predation behavior, Aquat. Toxicol. 148 (2014) 130–
138.
[17] P.P. Fong, N. Molnar, Antidepressants cause foot detachment from substrate in
five species of marine snail, Marine Environ. Res. 84 (2013) 24–30.
[18] P.P. Fong, A.T. Ford, The biological effects of antidepressants on the molluscs
and crustaceans: a review, Aquat. Toxicol. 151 (2014) 4–13.
[19] S. Giannakis, F.A. Gamarra Vives, D. Grandjean, A. Magnet, L.F. De Alencastro, C.
Pulgarin, Effect of advanced oxidation processes on the micropollutants and
the effluent organic matter contained in municipal wastewater previously
treated by three different secondary methods, Water Res. 84 (2015)
295–306.
[20] C. Comninellis, A. Kapalka, S. Malato, S.A. Parsons, I. Poulios, D. Mantzavinos,
Advanced oxidation processes for water treatment: advances and trends for
R&D, J. Chem. Technol. Biotechnol. 83 (2008) 769–776.
[21] A.I. Okoh, T. Sibanda, S.S. Gusha, Inadequately treated wastewater as a source
of human enteric viruses in the environment, Int. J. Environ. Res. Public Health
7 (2010) 2620–2637.
[22] T. Mackulˇak, L. Birošová, I. Bodík, R. Grabic, A. Takácˇová, M. Smolinská, A.
Hanusová, J. Híveš, M. Gál, Zerovalent iron and iron (VI): effective means for
the removal of psychoactive pharmaceuticals and illicit drugs from
wastewaters, Sci. Total Environ. 539 (2016) 420–426.
[23] M.J. García-Galán, A. Anfruns, R. Gonzalez-Olmos, S. Rodríguez-Mozaz, J.
Comas, UV/H2O2 degradation of the antidepressants venlafaxine and O-
desmethylvenlafaxine: elucidation of their transformation pathway and
environmental fate, J. Hazard. Mater. 311 (2016) 70–80.
[24] D. Lambropoulou, E. Evgenidou, V. Saliverou, C. Kosma, I. Konstantinou,
Degradation of venlafaxine using TiO2/UV process: kinetic studies, RSM
optimization, identification of transformation products and toxicity
evaluation, J. Hazard. Mater. (2016).
[25] R.O. Rahn, Potassium iodide as a chemical actinometer for 254 nm radiation:
use of lodate as an electron scavenger, Photochem. Photobiol. 66 (1997) 450–
455.
[26] B. Wols, C. Hofman-Caris, D. Harmsen, E. Beerendonk, Degradation of 40
selected pharmaceuticals by UV/H2O2, Water Res. 47 (2013) 5876–5888.
[27] R.A. Rodriguez, S. Bounty, S. Beck, C. Chan, C. McGuire, K.G. Linden,
Photoreactivation of bacteriophages after UV disinfection: role of genome
structure and impacts of UV source, Water Res. 55 (2014) 143–149.
[28] H.-G. Guo, N.-Y. Gao, W.-H. Chu, L. Li, Y.-J. Zhang, J.-S. Gu, Y.-L. Gu,
Photochemical degradation of ciprofloxacin in UV and UV/H2O2 process:
kinetics, parameters, and products, Environ. Sci. Pollut. Res. 20 (2013) 3202–
3213.
[29] H. Santoke, W. Song, W.J. Cooper, B.M. Peake, Advanced oxidation treatment
and photochemical fate of selected antidepressant pharmaceuticals in
solutions of Suwannee River humic acid, J. Hazard. Mater. 217 (2012) 382–
390.
[30] C.C. Ryan, D.T. Tan, W.A. Arnold, Direct and indirect photolysis of
sulfamethoxazole and trimethoprim in wastewater treatment plant effluent,
Water Res. 45 (2011) 1280–1286.
504 S. Giannakis et al. / Chemical Engineering Journal 308 (2017) 492–504[31] D. Vione, M. Minella, V. Maurino, C. Minero, Indirect photochemistry in sunlit
surface waters: photoinduced production of reactive transient species, Chem.-
Eur. J. 20 (2014) 10590–10606.
[32] C.J. Hoebe, H. Vennema, A.M. de Roda Husman, Y.T. van Duynhoven, Norovirus
outbreak among primary schoolchildren who had played in a recreational
water fountain, J. Infect. Dis. 189 (2004) 699–705.
[33] J.J. Pignatello, E. Oliveros, A. MacKay, Advanced oxidation processes for organic
contaminant destruction based on the fenton reaction and related chemistry,
Crit. Rev. Environ. Sci. Technol. 36 (2006) 1–84.
[34] P. Salgado, V. Melin, D. Contreras, Y. Moreno, H. Mansilla, Fenton reaction
driven by iron ligands, J. Chil. Chem. Soc. 58 (2013) 2096–2101.
[35] F.J. Millero, S. Sotolongo, The oxidation of Fe(II) with H2O2 in seawater,
Geochim. Cosmochim. Acta 53 (1989) 1867–1873.
[36] B. Morgan, O. Lahav, The effect of pH on the kinetics of spontaneous Fe(II)
oxidation by O2 in aqueous solution–basic principles and a simple heuristic
description, Chemosphere 68 (2007) 2080–2084.
[37] J.F. Barona, D.F. Morales, L.F. González-Bahamón, C. Pulgarín, L.N. Benítez, Shift
from heterogeneous to homogeneous catalysis during resorcinol degradation
using the solar photo-Fenton process initiated at circumneutral pH, Appl.
Catal. B 165 (2015) 620–627.
[38] S. Papoutsakis, S. Miralles-Cuevas, I. Oller, J.G. Sanchez, C. Pulgarin, S. Malato,
Microcontaminant degradation in municipal wastewater treatment plant
secondary effluent by EDDS assisted photo-Fenton at near-neutral pH: an
experimental design approach, Catal. Today (2015).
[39] N. Klamerth, S. Malato, A. Agüera, A. Fernández-Alba, G. Mailhot, Treatment of
municipal wastewater treatment plant effluents with modified photo-fenton
as a tertiary treatment for the degradation of micro pollutants and
disinfection, Environ. Sci. Technol. 46 (2012) 2885–2892.
[40] T. Mackulˇak, M. Mosny´, R. Grabic, O. Golovko, O. Koba, L. Birošová, Fenton-like
reaction: a possible way to efficiently remove illicit drugs and
pharmaceuticals from wastewater, Environ. Toxicol. Pharmacol. 39 (2015)
483–488.
[41] M. Qadir, D. Wichelns, L. Raschid-Sally, P.G. McCornick, P. Drechsel, A. Bahri, P.
Minhas, The challenges of wastewater irrigation in developing countries,
Agric. Water Manag. 97 (2010) 561–568.
[42] V. Cunningham, Special characteristics of pharmaceuticals related to
environmental fate, in: Pharmaceuticals in the Environment, Springer, 2004,
pp. 13–24.[43] S. Giannakis, M. Voumard, D. Grandjean, A. Magnet, L.F. De Alencastro, C.
Pulgarin, Micropollutant degradation, bacterial inactivation and regrowth risk
in wastewater effluents: influence of the secondary (pre)treatment on the
efficiency of Advanced Oxidation Processes, Water Res. 102 (2016) 505–515.
[44] S. Edberg, E. Rice, R. Karlin, M. Allen, Escherichia coli: the best biological
drinking water indicator for public health protection, J. Appl. Microbiol. 88
(2000).
[45] J. Margot, C. Kienle, A. Magnet, M. Weil, L. Rossi, L.F. De Alencastro, C.
Abegglen, D. Thonney, N. Chèvre, M. Schärer, Treatment of micropollutants in
municipal wastewater: ozone or powdered activated carbon?, Sci Total
Environ. 461 (2013) 480–498.
[46] R. Zhang, P. Sun, T.H. Boyer, L. Zhao, C.-H. Huang, Degradation of
pharmaceuticals and metabolite in synthetic human urine by UV, UV/H2O2,
and UV/PDS, Environ. Sci. Technol. 49 (2015) 3056–3066.
[47] S. Giannakis, M. Jovic, N. Gasilova, M. Pastor Gelabert, S. Schindelholz, J.-M.
Furbringer, H. Girault, C. Pulgarin, Iohexol degradation in wastewater and
urine by UV-based Advanced Oxidation Processes (AOPs): process modeling
and by-products identification, J. Environ. Management.
[48] Y. Lester, I. Ferrer, E.M. Thurman, K.G. Linden, Demonstrating sucralose as a
monitor of full-scale UV/AOP treatment of trace organic compounds, J. Hazard.
Mater. 280 (2014) 104–110.
[49] C. Boix, M. Ibáñez, J.V. Sancho, J.R. Parsons, P. de Voogt, F. Hernández,
Biotransformation of pharmaceuticals in surface water and during waste
water treatment: identification and occurrence of transformation products, J.
Hazard. Mater. 302 (2016) 175–187.
[50] X. Li, Y. Wang, J. Zhao, H. Wang, B. Wang, J. Huang, S. Deng, G. Yu, Electro-
peroxone treatment of the antidepressant venlafaxine: operational parameters
and mechanism, J. Hazard. Mater. 300 (2015) 298–306.
[51] S. Malato, P. Fernández-Ibáñez, M.I. Maldonado, J. Blanco, W. Gernjak,
Decontamination and disinfection of water by solar photocatalysis: recent
overview and trends, Catal. Today 147 (2009) 1–59.
[52] V. Sarria, S. Kenfack, O. Guillod, C. Pulgarin, An innovative coupled solar-
biological system at field pilot scale for the treatment of biorecalcitrant
pollutants, J. Photochem. Photobiol., A 159 (2003) 89–99.
[53] J. Lin, A. Ganesh, Water quality indicators: bacteria, coliphages, enteric viruses,
Int. J. Environ. Health Res. 23 (2013) 484–506.
[54] J.P. Nataro, J.B. Kaper, Diarrheagenic Escherichia coli, Clin. Microbiol. Rev. 11
(1998) 142–201.
